Pay in 4 interest-free payments of $5.47 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Innovations like these continue to push the boundaries of modern medicine and improve quality of life for millions
To view a copy of this licence, visit About this article Cite this article Uti, D.E., Atangwho, I.J., Alum, E.U
Potentially one the most debated points regarding the GLP-1 RA guidelines is how the recommended discontinuation of these medications may impact those with confounding conditions who may truly need them for either obesity management, glycemic control and possible benefits in heart failure, and chronic renal disease
Availability of data and materials All data generated or analyzed during this study are included in this published article [and its supplementary information files]
doi: 10.1038/nchembio.712
US$ 24.39
US$ 26.20
US$ 19.99
US$ 27.55
US$ 23.18
US$ 27.96
